ResearcherUniversity Hospital UlmNo recent work listed

Giulia Manzini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8032-8043; OpenAlex author ID A5033223720. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 2 papers

Papers 2

Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrospective cohort study. Last author DOI 10.1097/ms9.0000000000000854 ↗
Analysis of the CONKO-001 trial: Is the validity of the study sufficient to recommend adjuvant chemotherapy for pancreatic cancer? Last author DOI 10.3233/jrs-210015 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Katrin Bauer · 2 shared papers, 2023 · strength 0.57
- Paper Analysis of the CONKO-001 trial: Is the validity of the study sufficient to recommend adjuvant chemotherapy for pancrea… DOI 10.3233/jrs-210015 ↗
- Paper Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrosp… DOI 10.1097/ms9.0000000000000854 ↗
Peter Büchler · 1 shared paper, 2023 · strength 0.26
- Paper Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrosp… DOI 10.1097/ms9.0000000000000854 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.